期刊文献+

人促甲状腺激素受体HEK 293T细胞稳定表达株的构建 被引量:2

Stable Expression of Human Thyrotropin Receptor in HEK 293T Cells
原文传递
导出
摘要 目的构建人促甲状腺激素受体(hTSHR)稳定表达株,用于研究抗甲状腺新药。方法 AgeⅠ/NheⅠ双酶切载体GV266和hTSHR基因,T4连接酶连接构建GV266-hTSHR表达质粒。转染GV266-hTSHR到293T细胞后,Western blot证明hTSHR表达。用Opti-MEM、Lipofectamine 2000、辅助质粒在293T细胞构建GV266包装质粒。qPCR测定包装病毒滴度。用GV266包装质粒、GV266-hTSHR表达质粒共转染293T细胞获得GV266-hTSHR-293T稳定表达株。绿色荧光蛋白(GFP)荧光鉴定稳定表达株。结果 GV266-hTSHR构建物阳性大肠杆菌克隆的DNA测序结果与hTSHR序列比对100%吻合。Western blot显示,过表达hTSHR的HEK293T细胞出现相对分子质量为62×103的目的条带。qPCR测定包装质粒滴度达到了2×108 TU/mL。GV266-hTSHR-293T细胞稳定表达株表达GFP荧光。结论构建了GV266-hTSHR表达质粒,获得了GV266-hTSHRHEK 293T稳定表达株,为研究抗甲状腺多肽提供了必要的实验材料。 Objective To establish a strain of eukaryotic cells with overexpressed human thyrotropin receptor (hTSHR) for the development of anti-thyroid drugs. Methods GV266 vector and hTSHR gene were digested by Age I /Nhe I . Plasmids expressing GV266-hTSHR were constructed using T4 ligase and then transfected into 293T cells. The expression of hTSHR was determined by Western blot. Packaging plasmids were built in the 293T cells with Opti-MEM, Lipofectamine 2000 and helper plasmid. The titer of the packaging plasmids was determined with qPCR. The packaging plasmids and the plasmids expressing GV266-hTSHR were co-transfected into 293T cells to obtain a strain of cells (GV266-/iTSHK-293T) with stable expression of hTSHR. The GV266-hTSHR- 293T stain was detected by green fluorescent protein (GFP) fluorescence. Results The DNA sequence of GV266- hTSHR matched that of hTSHR. The Western blot showed a 62 X 10^3 target band. The titer of packaging plasmids reached 2 X 10^8 TU/mL. The GV266-ATSHR-293T cells were visible under GFP fluorescence. Conclusion HEK 293T cells with stable expression of hTSHR was established.
作者 唐恭顺
出处 《四川大学学报(医学版)》 CAS CSCD 北大核心 2014年第1期10-14,共5页 Journal of Sichuan University(Medical Sciences)
基金 国家自然科学基金(No.30970859)资助
关键词 人促甲状腺激素受体 慢病毒 HEK 293细胞 GRAVES甲亢 Human thyrotropin receptor Lentiviral vector HEK 293T cell Graves disease
  • 相关文献

参考文献15

  • 1Bjorkholm M, Pisa P, Arver S, et al. Haematologic effects of granuloeyte-macrophage colony stimulating factor in a patient with thiamazole-induced agranulocytosis. J Intern Med, 1992,232(5):443-445.
  • 2Biswas N, Ahn YH, Goldman JM, et al. Aplastic anemia associated with antithyroid drugs. Am J Med Sci, 1991, 301 (3) :190-194.
  • 3Memi E, Karras S, Tzotzas T, et al. Propylthiouracil hepatitis: report of a case and extensive review of the literature. J Pediatr Endocrinol Metab,2012,25(3 4) :331-343.
  • 4Sanders J, Jeffreys J, Depraetere H, et al. human monoclonal autoantibody to the thyrotropin sequence structure and function. Thyroid, 2004, 14 (8) : 560-570.
  • 5Sanders P, Young S, Sanders J, et al. Crystal structure of the TSH receptor (TSHR) bound to a blocking type TSHR autoantibody. J Mol Endocrinol,2011 ,46(2) :81-99.
  • 6Nunez Miguel R, Sanders J, Chirgadze DY, et al. Thyroid stimulating autoantibody M22 mimics TSH binding to the TSH receptor leucine rich domain: a comparative structural study of protein protein interactions. J Mol Endocrinol, 2009 , 42 ( 5 ) :381-395.
  • 7Neumann S, Kleinau G, Costanzi S, et al. A low-molecular weight antagonist for the human thyrotropin receptor with therapeutic potential for hyperthyroidism. Endocrinology, 2008,149(12) :5945-5950.
  • 8Tsui S, Naik V, Hoa N, et al. Evidence for an association between thyroid-stimulating hormone and insulin like growth factor 1 receptors= a tale of two antigens implicated in Graves* disease. J Immunol,2008,181(6):4397-4405.
  • 9Fukushima H, Mizutani M, Imamura K, et al. Development of a novel preparation method of recombinant proteoliposomes using baculovirus gene expression systems. J Biochem, 2008, 144(6):763-770.
  • 10Agretti P, Chiovato L, De Marco G, et al. Real-time PCR provides evidence for thyrotropin reeeptormRNA expression in orbital as well as in extraorbital tissues. Eur J Endocrinol, 2002,147(6):733 739.

同被引文献17

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部